Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: A randomized clinical trial

Journal of the American Academy of Dermatology

Volumn 64, Issue 3, 2011, Pages 606-608

  Emad, Maryam ^a   Hayati, Fariborz ^a   Fallahzadeh, Mohammad Kazem ^a   Namazi, Mohammad Reza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; PLACEBO;

CHEILITIS; CREATININE BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; LEISHMANIA MAJOR; LETTER; LOW DRUG DOSE; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

EID: 79951566608     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.04.014     Document Type: Article

References (3)

1. A.A. Alrajhi, E.A. Ibrahim, E.B. De Vol, M. Khairat, R.M. Faris, and J.H. Maguire Fluconazole for the treatment of cutaneous leishmaniasis caused by leishmania major N Engl Med 12 2002 891 895 (Pubitemid 34984637)
2. R. Reithinger, J.-C. Dujardin, H. Louzir, C. Primez, B. Alexander, and S. Brooker Cutaneous leishmaniasis review Lancet Infect Dis 7 2007 581 596
3. G. Morizot, P. Delgiudice, E. Caumes, E. Laffitte, P. Marty, and A. Dupuy Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution? Am J Trop Med Hyg 76 2007 48 52 (Pubitemid 351627801)